FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071302 [Registered on: 25/07/2024] Trial Registered Prospectively
Last Modified On: 13/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Evaluation of advanced dressing procedure in comparison with the standard dressing procedure for Healing long-term Wounds 
Scientific Title of Study   A Comparative Study on the Efficacy of Advanced PRF (A-PRF) versus Standard PRF (S-PRF) in treating Chronic Wounds, An Open-Label, Randomized Controlled Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
SDAP-032/01 version 01 Dated 06-05-2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ranganath V S 
Designation  Medical Director Consultant Plastic Surgeon  
Affiliation  Surgiderma Hospital 
Address  Department of Dermatology, 2nd Floor, Consultant Room, Surgiderma Hospital - Skin Hair Laser Plastic Surgery No. 5AC, 927, 5th A Cross Rd, HRBR Layout 1st Block, Babusapalya, Kalyan Nagar

Bangalore
KARNATAKA
560043
India 
Phone  8050620427  
Fax    
Email  ranganath.vitlapur@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Aditya V 
Designation  Assistant professor 
Affiliation  Gautham College of Pharmacy 
Address  Department of Pharmacy Practice, 3rd floor, Room No.3, Gautham College of Pharmacy Bhuvaneshwari nagar, R. T. Nagar post.

Bangalore
KARNATAKA
560032
India 
Phone  9008427619  
Fax    
Email  adithyavh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Jasmine S 
Designation  Research Coordinator 
Affiliation  Gautham College of Pharmacy 
Address  Department of Pharmacy Practice, 3rd floor, Room No.3,Gautham College of Pharmacy Bhuvaneshwari nagar, R. T. Nagar post.

Bangalore
KARNATAKA
560032
India 
Phone  9380717112  
Fax    
Email  jasminesarwan1@gmail.com  
 
Source of Monetary or Material Support  
Surgiderma Hospital - Skin Hair Laser Plastic Surgery No. 5AC 927, 5th A Cross Rd, HRBR Layout, 1st Block, Babusapalya, Kalyan Nagar, Bengaluru, Karnataka, India, 560043. 
 
Primary Sponsor  
Name  Dr Ranganath V S 
Address  Surgiderma Hospital - Skin Hair Laser Plastic Surgery No. 5AC, 927, 5th A Cross Rd, HRBR Layout 1st Block, Babusapalya, Kalyan Nagar 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ranganath V S   Surgiderma Hospital - Skin Hair Laser Plastic Surgery  Department of Dermatology, 2nd Floor, Consultant Room, No. 5AC, 927, 5th A Cross Rd, HRBR Layout 1st Block, Babusapalya, Kalyan Nagar
Bangalore
KARNATAKA 
8050620427

ranganath.vitlapur@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PRANAV DIABETES CENTER ETHICS COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 8||Other Procedures,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Advanced Platelet-Rich Fibrin (A-PRF)  15ml of venous blood will be drawn from the patients arm and centrifuged at 1500 rpm for 14 minutes to obtain A-PRF clots. Dressing procedure will be done using A-PRF clots once weekly for 4 weeks. 
Comparator Agent  Standard Platelet-Rich Fibrin (S-PRF)  15ml of venous blood will be drawn from the patients arm and centrifuged at 2700 rpm for 12 minutes to obtain S-PRF clots. Dressing procedure will be done using S-PRF clots once weekly for 4 weeks. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Participants with chronic wound for more than six weeks and have failed to heal by conventional treatments.
Wound size of less than 20cm2.
Both male and female participants.
Age 20 years or older.
Have a normal platelet count in range of 1,50,000- 4,50,000 cells/mm3.
Have a normal PT time: 11- 16 seconds.
Ability to provide informed consent or have a legally authorized representative able to provide consent on behalf of the participant.
Willingness to comply with study procedures and follow-up visits.
Adequate understanding of the study requirements and ability to communicate with study personnel. 
 
ExclusionCriteria 
Details  Presence of an active infection at the ulcer site.
Patients on anticoagulants (warfarin, heparin).
Pregnant and lactating women.
Patients suffering from leukaemia, septicaemia, impaired platelet function or other haematological disorders.
Patients with hypoproteinaemia.
Patients taking long term steroid containing drugs or using steroid ointments on wounds. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in mean size reduction of wound area from the baseline wound size.  Evaluation of wound size at week 2 and week 4 from baseline. 
 
Secondary Outcome  
Outcome  TimePoints 
Participants Quality of Life using Wound QoL-17 Questionnaire.  Evaluation of Participants Quality of Life at week 2 and week 4 from baseline. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Advanced Platelet rich fibrin  (A-PRF) represents a refinement of traditional PRF preparation techniques, aiming to enhance the concentration and bioactivity of growth factors within the fibrin matrix. This modification is hypothesised to improve the therapeutic potential of A-PRF in wound healing compared to Standard PRF (S-PRF). While both A-PRF and S-PRF have shown promise in wound healing, there remains a paucity of comparative studies evaluating their efficacy specifically in the context of chronic wound. This is an Open-Label Randomised Controlled Trial (RCT) comparing the efficacy of A-PRF versus S-PRF in treating chronic wounds. This research is warranted to provide evidence-based guidance for clinical practice and holds significant implications for advancing the field of wound care by elucidating the potential benefits of A-PRF over S-PRF in chronic wound management. 

 
Close